Candel Therapeutics Inc. (CADL)
NASDAQ · Healthcare
Candel Therapeutics Inc. Income Statement 2020–2022
| Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|
| Revenues | |||
| Revenue | 125,000 | 125,000 | 125,000 |
| Gross Profit | — | — | — |
| Profitability | |||
| Operating Income | -34.7M | -25.7M | -13.8M |
| EBITDA | -33.9M | -25.5M | -13.7M |
| Net Income | -18.8M | -36.1M | -17.7M |
| Per Share Data | |||
| EPS (diluted) | — | — | — |
| Shares Outstanding (dil.) | 29M | 19M | 12M |
Candel Therapeutics Inc. Income Statement — FAQ
Candel Therapeutics Inc. (CADL) income statement over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CADL's income statement history?
The chart and table above show Candel Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.